Singapore - Bristol-Myers Squibb enters into a research collaboration with Harvard Stem Cell Institute's Harvard Fibrosis Network, a group of researchers across the schools and affiliated hospitals of Harvard University, to discover and develop new treatments for fibrotic diseases, including the liver and heart.

Under the terms of the agreement, Harvard academic researchers will collaborate with BMY scientists on four projects over three years.